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Abstract: Peroxisomes are central to eukaryotic metabolism, including the oxidation of fatty
acids—which subsequently provide an important source of metabolic energy—and in the biosynthesis
of cholesterol and plasmalogens. However, the presence and nature of peroxisomes in the parasitic
apicomplexan protozoa remains controversial. A survey of the available genomes revealed that genes
encoding peroxisome biogenesis factors, so-called peroxins (Pex), are only present in a subset of these
parasites, the coccidia. The basic principle of peroxisomal protein import is evolutionarily conserved,
proteins harbouring a peroxisomal-targeting signal 1 (PTS1) interact in the cytosol with the shuttling
receptor Pex5 and are then imported into the peroxisome via the membrane-bound protein complex
formed by Pex13 and Pex14. Surprisingly, whilst Pex5 is clearly identifiable, Pex13 and, perhaps,
Pex14 are apparently absent from the coccidian genomes. To investigate the functionality of the PTS1
import mechanism in these parasites, expression of Pex5 from the model coccidian Toxoplasma gondii
was shown to rescue the import defect of Pex5-deleted Saccharomyces cerevisiae. In support of these
data, green fluorescent protein (GFP) bearing the enhanced (e)PTS1 known to efficiently localise to
peroxisomes in yeast, localised to peroxisome-like bodies when expressed in Toxoplasma. Furthermore,
the PTS1-binding domain of Pex5 and a PTS1 ligand from the putatively peroxisome-localised
Toxoplasma sterol carrier protein (SCP2) were shown to interact in vitro. Taken together, the se
data demonstrate that the Pex5–PTS1 interaction is functional in the coccidia and indicate that a
nonconventional peroxisomal import mechanism may operate in the absence of Pex13 and Pex14.
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1. Introduction
Peroxisomes were first biochemically characterised and named by Christian de Duve and
colleagues following purification from rat liver tissue, and later the protozoa [1,2]. Within the
isolated, membrane-bound microbodies, the y identified several oxidases that oxidize substrates whilst
reducing oxygen to hydrogen peroxide (H2O2), as well as two enzyme classes able to reduce this
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damaging H2O2: peroxidases and catalases [2]. The following decades saw peroxisomes identified
as apparently ubiquitous, functionally diverse, eukaryotic organelles involved in many catabolic
functions including lipid, amino acid and purine metabolism [3,4]. This biogenesis and functionality of
peroxisomes is dependent on a group of proteins known as peroxins (Pex). Furthermore, the topogenic
import signals for the import of matrix proteins is conserved across evolution [5]. For most imported
proteins this motif comprises a short tripeptide sequence at the extreme C-terminus. Prototypically,
this motif, serine–lysine–leucine (-SKL) or neutral variants, is known as peroxisomal-targeting signal
1 (PTS1) [6]. The PTS1 receptor is the peroxin Pex5, a shuttling receptor, which translocates the
PTS1-bearing ligand from the cytosol to the peroxisome matrix via interaction with a membrane
docking complex of Pex13 and Pex14 (and Pex17 in yeast) [7,8].
Illustrative of the essential function of peroxisomes in many eukaryotes is the association of
mutations in the Pex5–PTS1 import system with human diseases such as Zellweger syndrome [9].
However, despite the crucial roles these organelles can play, eukaryotic microbes such as the intestinal
parasite Entamoeba histolytica have been reported to lack peroxisomes, presumably due to their existence
in low-oxygen environments and the consequent lack of H2O2 [10]. Other intracellular parasites
such as the fungal Microsporidia and the protozoan Apicomplexa (including the malaria parasite
Plasmodium spp.), as well as intestinal parasitic helminths, have also been reported to lack peroxisomes
and encoded Pex proteins [4,11]. However, as the genome databases have developed it has become
clear that some apicomplexan parasites, the coccidia which include Eimeria spp. (coccidiosis in poultry)
and Toxoplasma gondii (toxoplasmosis), encode many of the Pex proteins synonymous with the presence
of these organelles [5].
Obligate intracellular organisms rely on the host cell for many of their nutritional requirements.
For example, Toxoplasma is auxotrophic for cholesterol and is reliant on that scavenged from the host
via endocytosis of low-density lipoprotein (LDL) [12,13], a process that has been proposed as a possible
drug target [14]. This salvage of LDL requires molecular mechanisms for coordinated delivery to the
desired organelles, and a sterol carrier protein (SCP2) has been characterised as playing a key role in
this process [15]. In the Eukaryota, SCP2 is specifically targeted to peroxisomes via a PTS1, a process
important for the β-oxidation of fatty acids [16]. Similarly, the Toxoplasma SCP2, which harbours a
putative PTS1 (SRL), is localised to peroxisomes in mammalian cells, and to the lumen of well-defined
vesicles in the parasite [15]. However, the identity of these vesicles as peroxisomes is controversial,
with the predicted PTS1 signal of Toxoplasma catalase failing to direct green fluorescent protein (GFP)
to membrane-bound microbodies in one study [17]. However, a parallel study showed the parasite
catalase localising to vesicles in Toxoplasma and to mammalian peroxisomes, with the putative PTS1
signal responsible [18].
Clearly, the nature and/or presence of peroxisomes in the Apicomplexa requires further
analyses. However, bioinformatic studies have very recently provided evidence, by virtue of the
presence of encoded Pex and PTS-bearing proteins, that Toxoplasma and related coccidia harbour
peroxisomes [5,19,20]. Here, we have taken a functional biology approach to define the Toxoplasma
Pex5 as a functional orthologue of the yeast, but not human, protein. In addition, we have shown
that the enhanced (e)PTS1 identified from Saccharomyces cerevisiae [21] efficiently localises GFP to
peroxisome-like bodies when expressed in Toxoplasma. Finally, we have biochemically demonstrated
that the PTS1 ligand domain of the parasite SCP2 interacts with the PTS1-binding domain from
Toxoplasma Pex5 in vitro. Taken together with previous studies, the se data strongly suggest the
presence of peroxisomes in this group of parasites.
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2. Materials and Methods
2.1. Toxoplasma Pex5 Complementation of Yeast and Human Mutant Lines
The complete coding region of the Toxoplasma protein, TgPex5 (TGGT1_231870), was synthesised
by GenScript (Piscataway, NJ, USA). Using the Infusion system (Takara, Kusatsu, Japan) according to
manufacturer’s instructions, this sequence was amplified and cloned into:
(i) the mammalian bicistronic expression vector pIRES2-enhanced(e)GFP-SKL [22] using the
primer pair:
F:5′CTCAAGCTTCGAATTCTGATGGCTTTCCGTGCG3′
R:5′GAGGGAGAGGGGCGGATCCGGTTAGACGTTCTTGATC3′
(ii) the yeast expression vector pRS416 (containing the ScPEX5 promoter) [23] using the
primer pair:
F:5′CAATATATCATAACACGTCGACTGATGGCTTTCCGTGCG3′
R:5′CTTAGCGGCCGCACTAGTAGATCTTTAGACGTTCTTGATCATCCC3′
The plasmid resulting from (i), pIRES2-TgPex5-eGFP-SKL, and pIRES2-HsPEX5-eGFP-SKL as
a positive control, were transfected into human skin fibroblast cell line GM5756 T (wild-type and
Zellweger patient-derived PEX5-deficient) [24]. Wild-type and mutant cells were maintained in
Dulbecco Modified Eagle Media (DMEM; Sigma Aldrich, St. Louis, MO, USA) supplemented with
10% Fetal Bovine Serum (FBS; ThermoFisher Scientific, Waltham, MA, USA), 4 mM L-glutamine (Sigma
Aldrich), 1% penicillin/streptomycin (Sigma Aldrich) at 37 ◦C, 5% CO2. Transfection was carried
out using the X-tremeGENE 9 DNA transfection kit (Roche, Basel, Switzerland) according to the
manufacturer’s protocol and the cells incubated for 72 h.
The plasmid resulting from (ii), pRS416-TgPex5, and pRS416-ScPex5 as a positive control (both
containing ScPEX5 promoter), were transformed into Saccharomyces cerevisiae UTL-7A (wild-type
and pex5 deletion strains) for growth assay, or co-transformed with pRS415-based plasmid encoding
GFP-SKL as a PTS1 peroxisomal marker for microscopy [23]. For transformation, yeast were grown to
exponential phase and transformed as previously described [25–30]. Single or double transformants
were selected on −Ura or −Ura−Leu plates, respectively, and later cultured in selective liquid media
containing 0.3% (w/v) glucose or 0.1% (w/v) oleic acid as previously described [31].
After incubation, human cells were washed with Dulbecco Phosphate-Buffered Saline (DPBS;
Sigma Aldrich) and fixed in 4% v/v paraformaldehyde (Roth, Karsruhe, Germany) in DPBS for
20 min at room temperature. Cells fixed on cover-slips were then mounted on glass slides under the
anti-fade reagent Mowiol (Sigma Aldrich) containing 4′,6-ciamidino-2-phenylindole (DAPI; ThermoFisher
Scientific). Yeast cells were directly visualized under microscopy. For imaging, wide-field fluorescence
microscopy was performed using an Axioplan 2 microscope with an AxioCam MR digital camera and
Axiovision software version 4.6.3 (Zeiss, Oberkochen, Germany). Green fluorescent protein signal was
visualized using 450–490 nm band pass excitation filter, a 510 nm dichromatic mirror and a 515–565 nm
band pass emission filter.
2.2. Growth Analyses of Toxoplasma Pex5 Complementation of Yeast Mutant Line
Serial 10-fold dilutions of exponentially growing UTL-7A Pex5 deleted yeast, transformed with
TgPex5, ScPex5 or empty vector, were spotted onto −Ura glucose or oleate plates and incubated at
30 ◦C for 3 to 4 days before image capture as previously described [31,32].
2.3. Localisation of Enhanced PTS1-Tagged GFP in Toxoplasma
The GFP-enhanced(e)PTS1 cassette was amplified from the vector pFA6a-GFP-eSKL [21] using
the primer pair:
F:5′GAAAACTACTCGTTGGCATTTTTTCTTGAATTCCATGAGTAAAGGAGAAGAACTTTT
CACTGG3′
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R:5′GAGAAGTGAGCACAACGGTGATTAATTAACTACAATTTGGATCTTCTACCTCTTCCC
AATG3′
Using the restriction-free methodology [33], following purification, the PCR product was cloned
into pTUB8-myc-GFP to form pTUB8-GFP-ePTS1.
Toxoplasma RH strain were transfected with pTUB8-GFP-ePTS1 and used to infect human foreskin
fibroblasts cultured on glass coverslips as previously described [29]. After 24 h, cells were fixed with
4% paraformaldehyde (20 min, room temperature) and washed in PBS, before permeabilization and
blocking in PBS/0.02% Triton-X-100/2% Bovine Serum Albumin (BSA; 20 min, room temperature).
Cells were then incubated for 60 min at room temperature with the primary antibodies (anti-IMC1 [34]
and anti-GFP, Roche) diluted 1:1000, washed three times, and incubated with Alexa488 goat
anti-mouse and Alexa594 goat anti-rabbit (ThermoFisher Scientific; 45 min, room temperature), all in
PBS/0.02% Triton-X-100/2% BSA.
Images were obtained using a DeltaVision Core microscope (GE Heathcare, Chicago, IL, USA)
and processed using Softworx (GE Heathcare) and FIJI software [35]. Parasites with heavily distorted
cell shape and fragmented mitochondria were excluded from the analysis.
2.4. Analyses of the Interaction of Toxoplasma Pex5 and SCP2
Regions encoding domains for the predicted PTS1 of TgSCP2 (TgSCP2PTS1: TgSCP2 499-625)
and the PTS1-binding region of receptor TgPex5 (TgPex5C: TgPex5 581-899) were synthesized with
an Escherichia coli codon bias and cloned into the bacterial expression vector pETM-30 by GenScript.
The resulting pETM-30-TgSCP2PTS1 and pETM-30-TgPex5C were transformed into E. coli BL21 (DE3)
(ThermoFisher Scientific), and grown in pH 7.5 buffered Luria-Bertani (LB) medium, supplemented
with 1% (w/v) glucose and 50 mg/mL kanamycin (Sigma-Aldrich) at 37 ◦C. When exponential growth
was reached, the temperature was reduced to 20 ◦C for 1 h, before induction with 0.5 mM IsoPropyl
β-D-1-ThioGalactopyranoside (IPTG; Sigma Aldrich) and overnight incubation at 30 ◦C. Cell pellets
were flash frozen before resuspension in Buffer A: 100 mM KH2PO4 pH 7.4, 5 mM 2-mercaptoethanol,
EDTA-free complete protease inhibitor cocktail, 1 mg/mL lysozyme, 1 mg/mL DNase I and 1 mg/mL
RNAse A (Sigma-Aldrich). The bacteria were then sonicated (Electronic UW2200; Bandelin, Berlin,
Germany) and, following centrifugation, the supernatant collected through a 0.45 µm filter (Sigma
Aldrich). This supernatant was then applied to a 1 mL Glutathione Sepharose 4B resin column (GSTrap)
(GE Healthcare), which was pre- equilibrated with Buffer A. Following a Buffer A wash, the protein was
eluted with Buffer A containing 20 mM reduced glutathione. The TgPex5C HIS-GST-tag was cleaved
using TEV protease (Sigma Aldrich) in accordance with manufacturer’s instructions, before dialysis
into Buffer A and application to a 1 mL Ni-NTA (ThermoFisher Scientific) column equilibrated in
Buffer A and eluted with Buffer A supplemented with 250 mM imidazole, pH 7.4. To analyse the
interaction, TgSCP2 PTS1 containing His6(HIS)-GST-tag was bound to a GSTrap column and isolated
TgPex5C applied in Buffer A. Following a Buffer A wash, the proteins were eluted with Buffer A
containing 20 mM reduced glutathione before analyses by SDS–PAGE.
3. Results
3.1. Functional Complementation Analyses of TgPex5 in Yeast and Human Cell Lines
Bioinformatic analyses of Toxoplasma, yeast and human Pex5 protein sequences indicated that
parasite Pex5 contains structural features characteristic of Pex5 proteins. The se include (i) C-terminal
TetratricoPeptide Repeat (TPR) motifs forming the PTS1-binding site; (ii) within the probably
unstructured N-terminal domain, three so-called WxxxF motifs required for receptor docking; and
(iii) a single cysteine at a conserved position, which becomes ubiquitinated to initiate recycling of
the receptor into the cytosol (Figure 1A). Toxoplasma Pex5 was heterologously expressed in human
or yeast cells for functional complementation analysis. In contrast to the positive control, human
HsPex5L [24], expression of Toxoplasma TgPex5 in Pex5-deficient human fibroblasts was unable to
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restore the PTS1-mediated trafficking of eGFP to peroxisomal compartments (Figure 2). However,
parallel analyses in S. cerevisiae demonstrated that TgPex5 could clearly restore GFP-PTS1 targeting to
peroxisomes in a cellular context (Figure 3). The results of this localisation assay were augmented by
the observation that TgPex5, like ScPex5 [23], was able to restore peroxisomal function and β-oxidation
as characterised by increased growth and the utilisation of fatty acid oleate, which results in halo
formation around the colonies on oleate plates (Figure 4) [31,32]. Growth complementation indicates
that the heterologous TgPex5 targets not only the artificial cargo GFP-PTS1, but also the endogenous
yeast enzymes, into peroxisomes. It is remarkable that TgPex5 restored translocation into the organellar
lumen of not only the β-oxidation enzymes with typical PTS1, but also of the non-PTS acyl-CoA oxidase
Fox1, the initial enzyme required for the fatty acid catabolic pathway. The Fox1 binding regions
have been assigned to the N-terminal half of ScPex5 [36]. Sequence alignments between yeast and
Toxoplasma Pex5 suggest that the key residues required for Fox1 interaction are largely conserved
(Figure 1B). Taken together, the se data indicate that Toxoplasma TgPex5 is a functional orthologue of
the yeast Pex5, and heterologous expression of this protein can functionally replace its yeast but not
its human counterpart.
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Figure 1. (A) Toxoplasma Peroxin 5 (Pex5) contains structural characteristics conserved in yeast and
human Pex5. Bioinformatic comparison of the Toxoplasma Pex5 protein sequence with yeast and human
counterparts indicated the presence of critical cysteine and lysine residues (C, K), pentapeptide motifs
(WxxxF/FxxxW) and structural domains (Pex7-binding region and TetratricoPeptide Repeat [TPR]
domains which bind peroxisomal-targeting signal 1 [PTS1] ligands) characteristic of Pex5. Additionally,
a region homologous to the Fox1 binding site in yeast Pex5 is also found in Toxoplasma Pex5; indicated
by black arrowheads. (B) Sequence alignment of the Fox1 binding site in yeast Pex5 (ScPex5251-267)
with Toxoplasma Pex5 (TgPex5442-456), arrows indicate positions in ScPex5 critical for Fox1 binding [36].
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cells (A), peroxisomal reporter enhanced (e) GFP-SKL is imported into peroxisomes, resulting in a
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Figure 3. TgPex5 complements for the loss of Pex5 in ∆pex5 mutant yeast when grown on medium
containing either glucose or oleate as the sole carbon source. No complementation is indicated by a
mislocalization of the heterologously expressed GFP-SKL to the cytosol as seen for the empty vector
control (A). Functional complementation restored peroxisomal import of the GFP-SKL and led to
the appearance of a punctate pattern, as seen upon expression of the gene coding for yeast Pex5 (B),
and the gene encodingTgPex5 (C). The se results indicated that TgPex5 can functionally replace the
yeast Pex5p in PTS1-protein import into peroxisomes. Scale bar is 5 µm.
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Figure 4. TgPex5 expression complements the growth defect of yeast ∆pex5 mutant cells on oleic
acid media. (A) Empty vector negative control; (B) ScPex5 positive control; and (C) TgPex5. 10-fold
dilutions (from the left) spotted onto either glucose and oleate plates. As expected, all strains grow well
in the presence of glucose. On oleate medium, the growth of the ∆pex5 mutant transformed with the
empty vector control is affected. In contrast, ∆pex5 mutant cells transformed with plasmids coding for
either ScPex5 (B) or TgPex5 (C) showed enhanced growth and a halo that is characteristic of efficient
oleate utilisation and peroxisomal oxidation (red stars).
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3.2. Localization of GFP Tagged with Enhanced PTS1 (GFP-ePTS1) in Toxoplasma
Enhanced (e)PTS1 was identified by screening a randomised library for linker sequences (directly
upstream of PTS1) for the ability to more efficiently localise fluorescent protein to peroxisomes in
S. cerevisiae [21]. When GFP-ePTS1 was expressed in Toxoplasma, it localised to punctate structures
with diameters ranging from 129–311 nm (Figure 5), this concurs with the diameter of peroxisomes
(100–200 nm) and previous observations in this parasite [15,18]. This observation supports
(i) the interaction of PTS1 (from yeast, as well as Toxoplasma) with Pex5 in the parasite; (ii) the existence
of peroxisomes with the canonical translocation machinery in the coccidia.
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Figure 5. GFP tagged with ePTS1 localised in peroxisome-like bodies when transiently expressed in
Toxoplasma. The image shows two parasites within a human fibroblast vacuole, GFP-ePTS1 stained with
anti-GFP antibody (A, green), the parasite pellicle stained with anti-IMC1 antibody (B, red), and a
merge of A and B (C). The scale bar is 1 µM.
3.3. In Vitro Analyses of the Interaction of TgPex5 and TgSCP2
Regions encoding the following domains were expressed i E. coli: (i) predicted TgSCP2 PTS1
(TgSCP2PTS1: TgSCP2 499–625) containing PTS1-targeting signal; and (ii) TgPex5 PTS1 receptor
(TgPex5C: TgP x5 581–899), harbouring the predicte PTS1-b nding domain. The recombinant proteins
were isolated and subjected to in vitro bi ding s udi s. Usi HIS-GST-tagged TgSCP2 PTS1 (43.4 kDa)
bound to a GSTrap column as bait, the binding of TgPex5C (34.5 kDa) was a alysed. Following
stringent washes, the elution of bound material demonstrated interaction with TgSCP2PTS1, showing
that the Toxoplasma Pex5 can bind to the parasite PTS1 (Figure 6).
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4. Discussion
With recent bioinformatic analyses demonstrating the presence of a suite of Pex proteins in the
coccidian apicomplexans, but not in other subclasses [5,19,20], functional analyses are demanded.
However, previous studies in Toxoplasma have proven to be controvertible. The Toxoplasma catalase was
localised to peroxisome-like vesicles in one study [18], however, in the same year it was reported that
the putative catalase PTS1 failed to direct GFP to these membrane-bound microbodies [17]. The sterol
carrier protein SCP2 has also been shown to localise to peroxisome-like bodies in Toxoplasma [15].
To improve the molecular understanding of the putative peroxisomal bodies in Toxoplasma and
the related coccidians, here we report a series of cellular and biochemical studies of the parasite Pex5
orthologue. Like human, plant and nematode [37], the Toxoplasma protein clearly rescues the targeting
of GFP bearing a canonical PTS1 sequence (SKL) in yeast, indicating that TgPex5 is a functional peroxin
involved in the trafficking of PTS1-bearing proteins to the peroxisomes. In addition, yeast-derived
ePTS1 was sufficient to localise GFP to peroxisome-like bodies in Toxoplasma [15,18], and TgSCPPTS1
(-SRL) clearly binds to the parasite TgPex5 PTS1-binding domain in vitro. Furthermore, heterologous
expression of TgPex5 restored the utilisation of oleate in Pex5-deficient yeast, clearly demonstrating that a
complete set of endogenous fatty acid-degrading enzymes with, and without, typical PTS1 sequences are
recognized and targeted to peroxisomes by the parasite peroxin. This common cargo selectivity of the yeast
and Toxoplasma receptor will include Fox1, which is recognized by a PTS1-independent binding domain
N-terminal of the yeast Pex5 PTS1-binding region. Importantly, unlike the mammalian orthologue, TgPex5
maintains a Fox1-binding region. In contrast to yeast, TgPex5 was unable to direct eGFP-SKL to human
fibroblast peroxisomes and thus rescue the import defect of an equivalent mammalian Pex5-deficient cell
line. Taken together, the se data indicate that TgPex5 is a functional orthologue of the yeast but not the
human peroxin. A difference that may be exploited by consideration of the TgPex5-PTS1 interaction as a
drug target, as has been described in the protozoan pathogen Trypansoma brucei [38].
Therefore, in summary we have demonstrated that the Toxoplasma Pex5 is functional in the context
of a ∆pex5 yeast strain and interacts with the protozoan PTS1 in vitro. Coupled with the localization of
ePTS1-tagged GFP to peroxisome-like bodies in Toxoplasma, this strongly suggests that the coccidia
harbour peroxisomes. The relative lack of structural evidence may be due to lifecycle-dependent
expression, with the peroxins characterised by upregulation during the extracellular stages of the
lifecycle, oocysts and sporozoites. Future studies should be directed here, rather than at the more
tractable, intracellular, tachyzoite forms [20]. In addition, in all eukaryotic systems studied to
date, a membrane-bound docking complex of Pex13 and Pex14 is required for peroxisomal protein
import [7,8]. However, an obvious Pex13 is missing in the genome of Toxoplasma and related coccidian
parasites [19,20]. Furthermore, the identity and presence of Pex14 in Toxoplasma is disputed [5,19,20].
The refore, the exact mode of Pex5-mediated protein import into peroxisomes in the coccidia is unclear
and further bioinformatic and functional analyses are warranted.
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